ORAL TU (316 MG BID) QUICKLY AND EFFECTIVELY INCREASES SERUM T CONCENTRATIONS IN HYPOGONADAL MEN

Buy Lab Tests Online

madman

Super Moderator
INTRODUCTION AND OBJECTIVE

Over 2.4 million US men have hypogonadism, defined as serum testosterone (T) levels <300 ng/dL. Negative effects associated with hypogonadism include development of metabolic syndrome, increased risk of coronary artery disease, decreased libido, low bone mineral density, and muscle loss. Oral T replacement therapies provide a route of administration that may be more appropriate for some patients’ needs. We present secondary analyses of T data from a phase 3 study of testosterone undecanoate which is approved in 158, 198, 237, 316, and 396 mg doses, with the goal of demonstrating that a large proportion of patients quickly achieved normal serum T levels.


METHODS

A phase 3, randomized, 12-month study was conducted to assess the safety and efficacy of oral testosterone undecanoate (TU) in 325 hypogonadal men. Men 18 to 75 yearswith morning serum T 300 ng/dL twice in one week were eligible. Eligible patients were randomized to oral TU or transdermal T-gel from Days 0 to 42. The initial oral TU dose was 316 mg TU twice a day (BID) (two 158 mg capsules orally). On Day 30±3 days, serum T sampling was done 4-6h after the morning dose. Serum T concentrations at Day 30 were evaluated for men treated with 316 mg TU BID.


RESULTS

158 men had serum T data. For men achieving serum T <450 and 450 ng/dL on Day 30 after initial dosing, mean baseline T was 234.04 and 218.5, and mean baseline BMI was 30 and 30, respectively. Overall, mean serum T was 874 ng/dL, 91% achieved serum T 300 ng/dL, 77% achieved serum T 450 ng/dL (Figure 1). See Figure 1 for distribution of T levels achieved with initial 316 mgTU BID.


CONCLUSIONS

Overall, 316 mg TU BID quickly and effectively increased serum T concentrations above 450 ng/dL in 77% of hypogonadal men. The wide distribution of serum T concentrations for the same dose (e.g., 23% <450 ng/dL and 27% 1000 ng/dL) suggests that men likely respond differently to T replacement therapy. Future studies and investigations should evaluate patient factors that impact the magnitude of T increases allowing for more individualized titrations.
 

Attachments

  • khera-et-al-2024-pd52-04-oral-testosterone-undecanoate-(316-mg-bid)-quickly-and-effectively-in...pdf
    79.3 KB · Views: 109
Defy Medical TRT clinic doctor
Screenshot (34836).png
 
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

bodybuilder test discounted labs
cheap enclomiphene
TRT in UK Balance my hormones
Discounted Labs
Testosterone Doctor Near Me
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
BUY HCG CIALIS

Online statistics

Members online
7
Guests online
6
Total visitors
13

Latest posts

Top